Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

RSS icon
artificial intelligence AI in the C suite

It’s 2024. Does the C-suite know—or care—what workers are doing with generative AI?

In the rush to do something, anything with AI, are America’s business leaders playing fast and loose with the risks? 

Epic sued by interoperability startup following dispute over patient data

Particle Health has accused Epic Systems of monopolistic business practices that hinder data-driven initiatives to improve patient care. Epic calls the complaint “baseless.” 

the words "FDA recall" on a board

FDA announces Class I recall for compounding inlets due to risk of death

Baxter’s disposable inlets for automated compounding systems could pose a serious risk to patients if not properly inspected before use.

California State Capitol Sacramento

Q&A: Healthcare attorney skeptical of California’s new private equity regulation

AB 3129 grants the Attorney General of California oversight of private equity transactions in healthcare. An attorney with Holland & Knight is concerned about the unintended consequences of the proposed law. 

Money bankruptcy debt liquidation

Atrium Health forgives patient debts, withdraws liens on 11,500 homes

The nonprofit hospital system stopped suing patients in 2022 and called debt cancellation the “next logical step.”

artificial intelligence AI in healthcare

UN effort afoot to address the world’s ‘governance deficit with respect to AI’

The AI advisory board of the United Nations is calling for the creation of a global AI data framework. 

healthcare providers and payers AI strategy

Providers trail payers in healthcare AI action

If putting an AI plan in place were a team sport, the Payers would be outpacing the Providers quite handily. 

pain pills opioids

Landmark opioid trial in Baltimore set to begin; Johnson & Johnson settles to avoid jury

Six companies have settled with the city for as total of over $402M. Two remaining defendants, McKesson and AmerisourceBergen, will test their luck in court.

Displaying 17 - 24 of 307

Around the web

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiovascular Business
Watchdog group, fearful of fraud, wants more oversight for remote patient monitoring

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Design by Adaptive Theme
Trimed Popup
Trimed Popup